Immunoblot assays in the different engineered cell lines verified ER/PR expression levels that were similar to endogenous receptors in T47D breast cancer cells and lack of receptors in parental and vector control DCIS.COM cells (Fig. 2a). The gene discussed is ESR1; the disease is breast cancer.